SelectScience
Join Free
ResourceLife Sciences

Product brochure: RarePlex Panel Kits

RareCyte, Inc
24 Jul 2022

In this product brochure, discover the RarePlex® Panel Kit family which are validated assays optimized for use with CyteFinder® Instruments and designed for enumeration and biomarker analysis of circulating tumor cells (CTCs).

Related products

Request Quote for All Products

RarePlex Panel Kits

RareCyte, Inc

The RarePlex Panel Kit product line includes immunofluorescence Panel Kits and Developer Kits for circulating tumor cell (CTC) characterization, including enumeration, and specific kits include additional biomarkers for in-depth phenotypic characterization. RarePlex Panel Kits are highly validated circulating tumor cell assays designed to work with the AccuCyte® Sample Preparation System, automated slide staining systems, and CyteFinder® Instruments. Developer Kits are single channel kits and enable you to keep up with the pace of discovery. In order to provide you with assay flexibility, Developer Kits were design to allow the addition of 1-2 biomarkers of your choice to a Panel Kit.

(0)

Links

RareCyte, IncCompany website

Tags

Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :TumorsTumor research focuses on understanding abnormal cell growth that leads to cancer. Identifying biomarkers, studying tumor microenvironments, and developing targeted therapies are critical for advancing cancer treatment. Early detection and personalized treatment options are key to improving outcomes for patients. Browse our peer-reviewed product directory to explore tools for tumor research, diagnostics, and cancer therapies; compare products, read customer reviews, and get pricing directly from manufacturers.Biomarker DiscoveryClinical biomarkers refer to substances related to known medical conditions that can be accurately measured <i>in vitro</i>. Biomarkers can be used to diagnose presence of a disease and indicate disease severity. The discovery of new biomarkers is incredibly valuable in the field of diagnostics.

Related resources

Product brochure: RarePlex Panel Kits